Evidence map›Paper›PMID 27809238›Full record

ReviewInternational journal of molecular sciences2016

Neuroglobin, a Factor Playing for Nerve Cell Survival.

Diego Guidolin, Cinzia Tortorella, Manuela Marcoli, Guido Maura, Luigi F Agnati

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Antioxidants (Basel, Switzerland) · 2021
    Article
  11. Article
  12. Article
  13. Article
  14. Auditory function and dysfunction: estrogen makes a difference.Cellular and molecular life sciences : CMLS · 2020
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Neuroglobin Can Prevent or Reverse Glaucomatous Progression in DBA/2J Mice.Molecular therapy. Methods & clinical development · 2017
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Diego GuidolinDepartment of Neuroscience, University of Padova, Padova 35122, Italy. diego.guidolin@unipd.it.
Cinzia TortorellaDepartment of Neuroscience, University of Padova, Padova 35122, Italy. cinzia.tortorella@unipd.it.
Manuela MarcoliDepartment of Pharmacy and Center of Excellence for Biomedical Research, University of Genova, Genova 16126, Italy. marcoli@pharmatox.unige.it.
Guido MauraDepartment of Pharmacy and Center of Excellence for Biomedical Research, University of Genova, Genova 16126, Italy. maura@pharmatox.unige.it.
Luigi F AgnatiDepartment of Biomedical Sciences, University of Modena and Reggio Emilia, Modena 41121, Italy. luigi.agnati@gmail.com.
University of Genoa · ITUniversity of Padua · ITUniversity of Modena and Reggio Emilia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cell death represents the final outcome of several pathological conditions of the central nervous system and available evidence suggests that in both acute injuries and neurodegenerative diseases it is often associated with mitochondrial dysfunction. Thus, the possibility to prevent mitochondrial events involved in cell death might represent efficient tools to limit neuronal damage. In recent years, increased attention has been paid to the endogenous protein neuroglobin, since accumulating evidence showed that its high expression was associated with preserved mitochondrial function and to an increased survival of nerve cells in vitro and in vivo in a variety of experimental models of cell insult. The biological and structural features of neuroglobin and the mitochondria-related mechanisms of neuroglobin-induced neuroprotection will be here briefly discussed. In this respect, the inhibition of the intrinsic pathway of apoptosis emerges as a key neuroprotective effect induced by the protein. These findings could open the possibility to develop efficient neuroglobin-mediated therapeutic strategies aimed at minimizing the neuronal cell death occurring in impacting neurological pathologies like stroke and neurodegenerative diseases.

Indexed as

AnimalsApoptosisCell SurvivalGlobinsHumansModels, BiologicalNerve Tissue ProteinsNeuroglobinNeuronsNeuroprotectionGlobinsNerve Tissue ProteinsNeuroglobinapoptosiscytochrome cmitochondrianeuroglobinprotein–protein interaction

Identifiers

PMID27809238
PMCPMC5133818
OpenAlexW2544717163

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.